Home > Items where Subject is "B Substances > New (novel) psychoactive substances > Synthetic cannabinoids (Spice / K2)"

up arrow imageUp a level
Export as
Group by: Item Type | No Grouping
Number of items at this level: 85.

Article

Kronstrand, Robert and Norman, Caitlyn and Vikingsson, Svante and Biemans, Anoek and Valencia Crespo, Bryan and Edwards, Darren and Fletcher, Daniel and Gilbert, Nicolas and Persson, Mattias and Reid, Robert and Semenova, Olga and Al Teneiji, Faisal and Wu, Xiongyu and Dahlén, Johan and NicDaéid, Niamh and Tarbah, Fuad and Sutcliffe, Oliver B and McKenzie, Craig and Gréen, Henrik (2022) The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons. Drug Testing and Analysis , 14 , (4) , pp. 634-652.

Craft, Sam and Dunn, Michael and Vidler, Dan and Officer, Jane and Blagbrough, Ian S and Pudney, Christopher R and Henderson, Graeme and Abouzeid, Ahmed and Dargan, Paul I and Eddleston, Michael and Cooper, Jamie and Hill, Simon L and Roper, Clair and Freeman, Tom P and Thomas, Simon H L (2022) Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act. Addiction , Early online .

Navarro-Tapia, Elisabet and Codina, Jana and Villanueva-Blasco, Víctor José and García-Algar, Óscar and Andreu-Fernández, Vicente (2022) Detection of the synthetic cannabinoids AB-CHMINACA, ADB-CHMINACA, MDMB-CHMICA, and 5F-MDMB-PINACA in biological matrices: a systematic review. Biology , 11 , (5) .

Bahji, Anees and Breward, Natasha and Duff, Whitney and Absher, Nafisa and Patten, Scott B and Alcorn, Jane and Mousseau, Darrell D (2022) Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review. Journal of Cannabis Research , 4 .

Downer, Eric J (2022) Editorial. Role of cannabinoids in inflammation. Molecules , 27 , (2) .

Adley, Mark and Atkinson, A M and Sumnall, Harry R (2022) Including the multiply excluded: a mixed methods study exploring intragroup stigma towards people who use synthetic cannabinoid receptor agonists. Drugs: Education Prevention and Policy , Early online .

Velayudhan, Latha and McGoohan, Katie and Bhattacharyya, Sagnik (2021) Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis. PLoS Medicine , 18 , (3) , e1003524.

Gray, Paul and Ralphs, Rob and Williams, Lisa (2021) The use of synthetic cannabinoid receptor agonists (SCRAs) within the homeless population: motivations, harms and the implications for developing an appropriate response. Addiction Research & Theory , 29 , (1) , pp. 1-10.

Fattore, Liana and Marti, Matteo and Mostallino, Rafaela and Castelli, Maria Paola (2020) Sex and gender differences in the effects of novel psychoactive substances. Brain Sciences , 10 , (9) .

Kourouni, Ismini and Mourad, Bashar and Khouli, Hassan and Shapiro, Janet M and Mathew, Joseph P (2020) Critical illness secondary to synthetic cannabinoid ingestion. JAMA Network Open , 3 , (7) , e208516.

Lipnik-Štangelj, Metoda and Razinger, Barbara (2020) A regulatory take on cannabis and cannabinoids for medicinal use in the European Union. Archives of Industrial Hygiene and Toxicology , 71 , (1) , pp. 12-18.

Alam, Ryan M and Keating, John J (2020) Adding more "spice" to the pot: a review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists. Drug Testing and Analysis , 12 , (3) , pp. 297-315.

Freeman, Tom P and Hindocha, Chandni and Green, Sebastian F and Bloomfield, Michael AP (2019) Medicinal use of cannabis based products and cannabinoids. BMJ (Clinical Research ed.) , 365 , l1141.

Drug and Alcohol Findings. (2017) Cannabis is worth bothering about. Drug and Alcohol Findings Hot Topic , (10 July 2017) .

Fischer, Benedikt and Russell, Cayley and Sabioni, Pamela and van den Brink, Wim and Le Foll, Bernard and Hall, Wayne and Rehm, Jürgen and Room, Robin (2017) Lower-risk cannabis use guidelines: a comprehensive update of evidence and recommendations. American Journal of Public Health , 107 , (8) , e1-e12.

Van Hout, Marie Claire and Hearne, Evelyn (2017) User experiences of development of dependence on the synthetic cannabinoids, 5f-AKB48 and 5F-PB-22, and subsequent withdrawal syndromes. International Journal of Mental Health and Addiction , 15 , (3) , pp. 565-579.

Boyle, Michelle (2016) 4th International Conference on Novel Psychoactive Substances, Budapest, 30‒31 May 2016. Drugnet Ireland , Issue 59, Autumn 2016 , pp. 19-20.

Pike, Brigid (2016) Terminology and information on drugs. Drugnet Ireland , Issue 57, Spring 2016 , p. 13.

Prenderville, Jack A and Kelly, Áine M and Downer, Eric J (2015) The role of cannabinoids in adult neurogenesis. British Journal of Pharmacology , 172 , (16) , pp. 3950-3963.

Lutge, Elizabeth L and Gray, Andy and Siegfried, Nandi (2013) The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS. Cochrane Database of Systematic Reviews , (4) .

Grigoryev, A and Kavanagh, Pierce and Melnik, A (2012) The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography-mass spectrometry. Drug Testing and Analysis , 4 , (6) , pp. 519-524.

Kavanagh, Pierce and Grigoryev, A and Melnik, A and Simonov, A (2012) The identification of the urinary metabolites of 3-(4-Methoxybenzoyl)-1-Pentylindole (RCS-4), a novel cannabimimetic, by gas chromatography–mass spectrometry. Journal of Analytical Toxicology , 36 , (5) , pp. 303-311.

Connolly, Johnny (2011) Legal update. Drugnet Ireland , Issue 37, Spring 2011 , pp. 25-26.

Long, Jean (2010) Conference on psychoactive drugs sold in head shops and online. Drugnet Ireland , Issue 33, Spring 2010 , pp. 1-3.

Report

Krotulski, Alex J and Shinefeld, Jennifer and Fogarty, Melissa F and DeBord, Joshua and Logan, Barry K (2022) CH-FUBIATA. Pennsylvania: Center for Forensic Science Research and Education.

European Monitoring Centre for Drugs and Drug Addiction. (2022) New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System. Luxembourg: Publications Office of the European Union.

Krotulski, Alex J and Farrell, Ryan and Mohaupt, Amanda and Fogarty, Melissa F and Walton, Sara E and Logan, Barry K (2022) CH-PIATA. Pennsylvania: Center for Forensic Science Research and Education.

Center for Forensic Science Research and Education. (2022) Novel psychoactive substances (NPS) 2022 trend reports. Pennsylvania: Center for Forensic Science Research and Education.

National Poisons Information Centre. (2021) National Poisons Information Centre annual report 2020. Dublin: National Poisons Information Centre.

Center for Forensic Science Research and Education. (2021) NPS discovery: BZO-CHMOXIZID. Pennsylvania: Center for Forensic Science Research and Education.

United Nations Office on Drugs and Crime. (2021) UNODC Synthetic drug strategy 2021-2025. Vienna: United Nations Office on Drugs and Crime.

Auwärter, Volker and de Morais, Joanna and Gallegos, Ana and Evans-Browns, Michael and Christie, Rachel and Jorge, Rita and Sedefov, Roumen (2021) Synthetic cannabinoids in Europe – a review. Luxembourg: Publications Office of the European Union.

Public Health England. (2021) Drug Harms Assessment and Response Team. Quarterly summary for professionals: May 2021. London: Public Health England.

National Institute for Health and Care Excellence. (2021) Cannabis-based medicinal products. London: NICE.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2020) EMCDDA technical report on the new psychoactive substance methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3- dimethylbutanoate (4F-MDMB-BICA). Lisbon: EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2020) EMCDDA technical report on the new psychoactive substance methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA). Lisbon: EMCDDA.

Department of Social Welfare, City of Zurich. Schori, Dominique (2020) C-EHRN briefing paper. Amsterdam: Correlation – European Harm Reduction Network.

European Monitoring Centre for Drugs and Drug Addiction. (2020) EMCDDA initial report on the new psychoactive substance methyl 2-({[1-(4-fluorobutyl)-1H-indol-3-yl]carbonyl}amino)-3,3-dimethylbutanoate (4F-MDMB-BICA). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2020) EMCDDA initial report on the new psychoactive substance methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (MDMB-4en-PINACA). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Advisory Council on the Misuse of Drugs. (2020) Synthetic cannabinoid receptor agonists (SCRA). An updated harms assessment and a review of classification and scheduling under the Misuse of Drugs Act 1971 and its Regulations. London: Advisory Council on the Misuse of Drugs.

Global SMART Programme. (2020) Synthetic drugs in East and Southeast Asia. Latest developments and challenges. Vienna: United Nations Office on Drugs and Crime.

European Monitoring Centre for Drugs and Drug Addiction. (2019) Developments in the European cannabis market. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation. An update from the EU Early Warning System. Luxembourg: Publications Office of the European Union.

CDC Health Alert Network. (2018) Outbreak of life-threatening coagulopathy associated with synthetic cannabinoids use. Atlanta: US Department of Health & Human Services.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2018) Report on the risk assessment of 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2018) Report on the risk assessment of N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

Manchester Health & Care Commissioning. (2017) Spice. Synthetic cannabinoids (SCRAs). Manchester Health & Care Commissioning.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Perspectives on drugs: Synthetic cannabinoids in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Ryan, George (2017) Novel psychoactive substances: synthetic cannabinoids - best practice treatment approaches. London: SMMGP.

Forensic Science Ireland. (2017) Forensic Science Ireland annual report 2016. Dublin: Forensic Science Ireland.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Report on the risk assessment of methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

Van Hout, Marie Claire and Hearne, Evelyn (2015) A community based study of synthetic cannabinoid use in Co. Monaghan, Ireland. Monaghan: Teach na Daoine Family Resource Centre.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Perspectives on drugs: Synthetic cannabinoids in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Novel Psychoactive Treatment UK Network. Abdulrahim, D and Bowden-Jones, O (2015) Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances. London: NEPTUNE.

European Monitoring Centre for Drugs and Drug Addiction. (2015) New psychoactive substances in Europe. An update from the EU Early Warning System March 2015. Luxembourg: Publications Office of the European Union.

Laboratory and Scientific Section, United Nations Office on Drugs and Crime. (2013) The challenge of new psychoactive substances. A report from the Global SMART Programme. Vienna: United Nations Office on Drugs and Crime.

Advisory Council on the Misuse of Drugs. (2012) Further consideration of the synthetic cannabinoids. London: Home Office.

United Nations Office on Drugs and Crime. (2012) Global SMART update 2012. Update 8. Vienna: United Nations Office on Drugs and Crime.

EMCDDA, EUROPOL. (2011) EMCDDA–Europol 2010 annual report on the implementation of Council Decision 2005/387/JHA. Lisbon: European Monitoring Centre for Drugs and Drug Addiction & EUROPOL.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2010) EMCDDA–Europol 2009 annual report on the implementation of Council Decision 2005/387/JHA. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

European Monitoring Centre for Drugs and Drug Addiction. (2009) EMCDDA 2009 thematic paper: Understanding the 'Spice' phenomenon. Luxembourg: Publications Office of the European Union.

Advisory Council on the Misuse of Drugs. (2009) Consideration of the major cannabinoid agonists. London: Home Office.

Webpage

European Monitoring Centre for Drugs and Drug Addiction. (2021) Spotlight on… Synthetic cannabinoids. URL: https://www.emcdda.europa.eu/spotlights/synthetic-...

FactSheet

HRB National Drugs Library. (2022) Factsheet: New psychoactive substances (NPS) - the Irish situation. Dublin: HRB National Drugs Library.

National Institute on Drug Abuse. (2020) DrugFacts: Synthetic cannabinoids (K2/Spice). Bethesda, MD: National Institute on Drug Abuse.

Drugs.ie. (2017) The strength of your cannabinoid may be higher than you think. Synthetic Cannabinoids (‘Spice’). Dublin: drugs.ie.

Cunningham, Andrew and Gallegos, Ana and Francis, Will and Evans-Browns, Michael (2015) Harms arising from the use of synthetic cannabinoid products. European Monitoring Centre for Drugs and Drug Addiction.

Ballyfermot Advance Project, Base Youth and Child Centre, Ballyfermot. (2010) Legal highs & headshops: some basic facts. Dublin: Ballyfermot Drugs Task Force.

Dail Debates

[Oireachtas] Dail Eireann debate. Written answer 453 - Controlled drug sales [Black Mamba] [14008/12]. (13 Mar 2012)

[Oireachtas] Dail Eireann debate. Written answer 74 - National Drugs Strategy [Head shops] [39804/09]. (05 Nov 2009)

Video

Darke, Shane and Banister, Samuel (2021) NDARC Webinar series. A dangerous misnomer: 'synthetic cannabis'. National Drug and Alcohol Research Centre.

Dataset

Center for Forensic Science Research & Education. (2021) NPS discovery dashboard [United States].

News

[EMCDDA] Two new synthetic cannabinoids to be placed under control across the EU. (14 May 2018)

[thejournal.ie] , Burke, Ceimin The government just outlawed four popular 'designer' drugs. (22 Nov 2017)

[thejournal.ie] , Brophy, Daragh A drug with 'zombie-like' effects is causing huge problems in Manchester. So what is it? (15 Apr 2017)

[European Monitoring Centre for Drugs and Drug Addiction] MDMB-CHMICA to be placed under control across the EU. (27 Feb 2017)

[thejournal.ie] , Brophy, Daragh Crack cocaine and synthetic cannabinoids. Concern over new drug trends in Dublin. (27 Dec 2016)

[Irish Examiner] , O'Keeffe, Cormac Record number of synthetic chemicals detected. (01 Jun 2013)

European Monitoring Centre for Drugs and Drug Addiction. Leading experts to review global developments in new drugs and ‘legal highs’. (07 Jun 2012)

[thejournal.ie] Taking new illicit drugs is like playing ‘a dangerous game of roulette’. (26 Apr 2012)

[Health Research Board] New report reveals the latest drug trends across Europe. (15 Nov 2011)

EMCDDA, EUROPOL. [EMCDDA] New drugs becoming available at ‘unprecedented pace’, says report. (11 May 2011)

[Department of Health and Children] Opening statement for meeting of Joint Committee on Health and Children in relation to recent legislation made to control certain substances under the Misuse of Drugs Act 1977. (01 Jun 2010)

[Department of Health and Children] Department of Health and Children statement in relation to legislation to be made under Misuse of Drugs Act 1977. (03 Mar 2010)

[European Monitoring Centre for Drugs and Drug Addiction & Health Research Board] Latest drug trends across Europe. HRB compares Irish situation with European findings. (05 Nov 2009)

This list was generated on Sun Jul 3 04:10:28 2022 IST.